What is the CPT (Current Procedural Terminology) code for a transvaginal ultrasound to diagnose or monitor endometrial hyperplasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CPT Code for Transvaginal Ultrasound for Endometrial Hyperplasia

The CPT code for transvaginal ultrasound to evaluate endometrial hyperplasia is 76830 (Ultrasound, transvaginal).

Primary CPT Code

  • CPT 76830 is the standard code for transvaginal ultrasound examination of the uterus and adnexa, which includes evaluation of the endometrium for suspected hyperplasia 1, 2
  • This code encompasses measurement of endometrial thickness, assessment of endometrial echogenicity, and evaluation of the endometrial-myometrial interface 3

Additional CPT Codes That May Apply

  • CPT 76831 may be used if a more comprehensive transvaginal ultrasound is performed with detailed evaluation of the uterus, adnexa, and surrounding structures 4
  • CPT 76817 (Ultrasound, pregnant uterus, real time with image documentation, transvaginal) should NOT be used for endometrial hyperplasia evaluation, as this is specific to obstetric indications
  • CPT 76830 with modifier 26 if only the professional component (interpretation) is being billed separately from the technical component

When Combined Procedures Are Performed

  • If both transabdominal and transvaginal ultrasound are performed together (which is recommended practice), both CPT 76856 (pelvic ultrasound, complete) and 76830 may be billed, as the American College of Radiology considers these complementary procedures 4
  • CPT 58340 (saline infusion sonohysterography) is a separate procedure code if sonohysterography is performed to further characterize a focal endometrial abnormality identified on initial transvaginal ultrasound 4, 1

Documentation Requirements for Proper Coding

  • The ultrasound report must document endometrial thickness measurement (double-layer thickness at the thickest portion), endometrial echogenicity, contour regularity, and presence of any focal lesions 3
  • Color Doppler evaluation of endometrial vascularity, while considered standard practice by ACR, is typically included in CPT 76830 and does not require separate coding 4
  • The indication for the study (abnormal uterine bleeding, suspected endometrial hyperplasia, postmenopausal bleeding) should be clearly documented with appropriate ICD-10 codes 1

Common Coding Pitfalls to Avoid

  • Do not use obstetric ultrasound codes (76801-76817 series) for gynecologic indications like endometrial hyperplasia
  • Ensure that if both transabdominal and transvaginal approaches are used, both are documented in the report to justify billing both codes 4
  • Doppler evaluation is considered an integral component of pelvic ultrasound and should not be separately coded unless specifically requested as a standalone study 4

References

Guideline

Diagnostic Approach to Abnormal Uterine Bleeding - Endometrial Causes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chinese guidelines on the management of endometrial hyperplasia.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2024

Guideline

Measuring Endometrial Thickness on Transvaginal Ultrasound

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.